Health
Even low-dose oral glucocorticoid use associated with increased CV risk – medwireNews
UK research has identified a “strong dose-dependent” association between oral glucocorticoid use and CVD risk among people with immune-mediated diseases, with an…
medwireNews: UK research has identified a strong dose-dependent association between oral glucocorticoid use and cardiovascular disease (CVD) risk among people with immune-mediated diseases, with an increased risk seen even at prednisolone-equivalent doses of less than 5 mg/day.
These results highlight the importance of prompt and regular monitoring of cardiovascular risk and use of primary prevention treatment at all glucocorticoid doses, write the researchers in PLOS Medicine.
Mar Pujades-Rodriguez…
-
General20 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General22 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Noosa News18 hours agoSerious traffic crash, Noosa – Sunshine Coast
-
Business22 hours agoTop brokers name 3 ASX shares to buy next week 12 October 2025